CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Cervical Cancer Awareness Month: 2022 Immunotherapy Research Updates

    New research, new treatments, and how we’re working toward a future immune to cervical cancer

    January 12, 2022| CRI Staff
  • Gynecologic Cancer Awareness Month: 2021 Immunotherapy Research Updates

    This September for Gynecologic Cancer Awareness Month, we reflect on new treatments, research discoveries, and how CRI…

    September 3, 2021| Gabriella Rojas
  • Cervical Cancer Awareness Month: 2021 Immunotherapy Research Updates

    This January for Cervical Cancer Awareness Month, we look at new research, new treatments, and how we’re…

    January 6, 2021| CRI Staff
  • Ovarian Cancer and Immunotherapy Breakout Session at the 2020 CRI Virtual Immunotherapy Patient Summit

    Dr. Kunle Odunsi discusses genomic testing, new treatments, and promising clinical trials in immunotherapy for ovarian cancer.

    November 23, 2020| Caroline Offit
  • Gynecologic Cancer Awareness Month: 2020 Immunotherapy Research Updates

    This September for Gynecologic Cancer Awareness Month, we look at new FDA approvals, new research, and how…

    September 10, 2020| CRI Staff
  • How Immunotherapy is Making an Impact in Gynecologic Cancers

    For Gynecologic Cancer Awareness Month, CRI spoke with Dr. Kunle Odunsi about immunotherapies for ovarian, cervical, and…

    September 8, 2020| Arthur N. Brodsky, PhD
  • Vaccine-Chemo Combo Shows Promise in Treating Advanced, HPV-Associated Cervical Cancer

    Combined with chemotherapy, an HPV-targeting vaccine developed by CRI scientists led to encouraging responses in women with…

    March 27, 2020| Arthur N. Brodsky, PhD
  • Cervical Cancer Awareness Month: 2020 Immunotherapy Research Update

    News and research from Drs. Claire Friedman, Ian Frazer, and Cornelis Melief on changing the future of…

    January 28, 2020| CRI Staff
  • ASCO 2016 Update: Immunotherapy Strategies for Women’s Cancers

    Improving immunotherapy for breast, ovarian, and gynecological cancer patients.

    June 6, 2016| Arthur N. Brodsky, PhD
1 2
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute

Group of three cancer survivors

Your support saves lives

Double Your Impact Today

On #Immune2Cancer Day, your gift matched up to $50,000

Photo of Cancer Survivors: Brendan Connors, Karen Peterson, and Tom Vibert